What is Insmed's astrazeneca milestone — intangibles, net?

Insmed (INSM) reported astrazeneca milestone — intangibles, net of $43.23M in Q1 2026.

What does astrazeneca milestone — intangibles, net mean?

This represents the net carrying value of intangible assets acquired through milestone-based licensing or collaboration agreements with AstraZeneca. It reflects the capitalized cost of intellectual property rights, net of accumulated amortization, that are currently contributing to the company's asset base. This metric is critical for assessing the long-term value of external partnerships in the company's R&D portfolio.

Insmed INSM AstraZeneca milestone — Intangibles, net

Similar metrics at other companies

NUVBIntangible Assets Net Of Amortization

$1.86M+314%

INCYIntangibles (Net)

$103.2M-18.4%

BIIBIntangibles (Net)

$7.25B-6.7%

WSTIntangibles (Net)

$6.4M-34.0%

MOG.BIntangibles (Net)

$60.54M+4.5%

AXSMIntangibles (Net)

$38.95M-14.1%

Other financials

Income statement

See full

Revenue$306.0M+230%

Gross profit$258.5M+261%

Operating income-$153.3M+38.2%

Net income-$163.6M+36.3%

EPS (diluted)-$0.76+46.5%

Balance sheet

See full

Cash & equivalents$582.2M+44.4%

Total debt$580.3M-49.2%

Total equity$704.9M+611%

Total assets$2.1B+15.2%

Cash flow

See full

Operating cash flow-$222.7M+15.0%

CapEx$3.5M-65.4%

Free cash flow-$226.2M+16.9%

Valuation

See full

Market cap$23.18B+19.9%

Enterprise value$23.17B+24.5%

P/S28.3×-20.3×

Profitability

See full

Gross margin81.8%+5.3pp

Operating margin-140.6%-43.9pp

Net margin-144.4%-45.3pp

FCF margin-112.5%-35.3pp

Returns & leverage

See full

Return on equity-294.5%—

Debt / equity0.8×-10.7×

Current ratio4.5×-1.4×

Where this comes from

Reported directly by Insmed in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The official record: Insmed’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insmed's astrazeneca milestone — intangibles, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Insmed's astrazeneca milestone — intangibles, net?: Insmed (INSM) reported astrazeneca milestone — intangibles, net of $43.23M in Q1 2026.
What does astrazeneca milestone — intangibles, net mean?: This represents the net carrying value of intangible assets acquired through milestone-based licensing or collaboration agreements with AstraZeneca. It reflects the capitalized cost of intellectual property rights, net of accumulated amortization, that are currently contributing to the company's asset base. This metric is critical for assessing the long-term value of external partnerships in the company's R&D portfolio.